NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Remission Medical

Remission Medical

Private
VirginiaHealthcare & Life Scienceshttps://remissionmedical.com/

Last Round

Series A

Apr 9, 2026

Total Funding Raised

$7.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Remission Medical is a healthcare company that provides a virtual rheumatology platform to expand access to care by partnering with health systems and specialty practices.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, EHR & EMR, Medical AI, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

rheumatology carevirtual-first careclinical workforce extensionworkforce management platformEHR integrationelectronic health recordsEHRmedical AIrevenue cycle automationtelemedicinevertical SaaShealthcare capacity managementphysician staffingvirtual care platformai-native healthcareclinical workflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remission Medical Comparables

Compare Remission Medical with similar companies based on industry and business-model similarity.

Remission Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sevaro Health
82%
AmplifyMD
82%
KeyCare
78%

Remission Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 9, 2026

Key People

Founding team and executive leadership

Blake Wehman

Founder CEO

Founding Team

Tyler Beard

Chief Technology Officer

Executive Team

Bhavika Amin

Chief Clinical Officer, Chief Operating Officer

Executive Team

Remission Medical Investors

Notable investors and investment history

Remission Medical investors
InvestorRounds
Blue Heron CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    $5M round completed.

  • Dec 24, 2025

    Grew 21% QoQ from 19 to 23 employees.

Remission Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remission Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remission Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersVirginia
Employee Range29
Year Founded2022
Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.